Your browser doesn't support javascript.
loading
Understanding innovation of health technology assessment methods: the IHTAM framework.
Jiu, Li; Hogervorst, Milou A; Vreman, Rick A; Mantel-Teeuwisse, Aukje K; Goettsch, Wim G.
Afiliação
  • Jiu L; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Hogervorst MA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Vreman RA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
  • Mantel-Teeuwisse AK; National Health Care Institute, Diemen, The Netherlands.
  • Goettsch WG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Int J Technol Assess Health Care ; 38(1): e16, 2022 Jan 31.
Article em En | MEDLINE | ID: mdl-35094736
ABSTRACT
Adequate methods are urgently needed to guarantee the good practice of health technology assessment (HTA) for technologies with novel properties. The aim of the study was to construct a conceptual framework to help understand the innovation of HTA methods (IHTAM). The construction of the IHTAM framework was based on two scoping reviews, one on the current practice of innovating methods, that is existing HTA frameworks, and one on theoretical foundations for innovating methods outside the HTA discipline. Both aimed to identify and synthesize concepts of innovation (i.e., innovation processes and roles of stakeholders in innovation). Using these concepts, the framework was developed in iterative brainstorming sessions and subsequent discussions with representatives from various stakeholder groups. The framework was constructed based on twenty documents on innovating HTA frameworks and fourteen guidelines from three scientific disciplines. It includes a generic innovation process consisting of three phases ("Identification," "Development," and "Implementation") and nine subphases. In the framework, three roles that HTA stakeholders can play in innovation ("Developers," "Practitioners," and "Beneficiaries") are defined, and a process on how the stakeholders innovate HTA methods is included. The IHTAM framework visualizes systematically which elements and stakeholders are important to the development and implementation of novel HTA methods. The framework could be used by all stakeholders involved in HTA innovation to learn how to engage dynamically and collaborate effectively throughout the innovation process. HTA stakeholders in practice have welcomed the framework, though additional testing of its applicability and acceptance is essential.
Assuntos
Palavras-chave

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Avaliacao_tecnologia Bases de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica Tipo de estudo: Guideline / Health_technology_assessment / Qualitative_research Idioma: En Revista: Int J Technol Assess Health Care Assunto da revista: PESQUISA EM SERVICOS DE SAUDE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Avaliacao_tecnologia Bases de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica Tipo de estudo: Guideline / Health_technology_assessment / Qualitative_research Idioma: En Revista: Int J Technol Assess Health Care Assunto da revista: PESQUISA EM SERVICOS DE SAUDE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda